## RUN: Sunrun Inc. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.45 indicates fundamental undervaluation. Consistent execution (3/4 quarters beat estimates). Caution: declining volume (58% of avg).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($15.38)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 7
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Sunrun director Fenster sells $2.4 million in shares By Investing.com**
- Source: Investing.com UK | 20251209T015600 | Neutral | Relevance: 99%
-  Sunrun Inc. Director Edward Harris Fenster sold 133,256 shares of common stock for approximately $2.4 million on December 5, 2025, to cover exercise costs and tax obligations related to stock option exercises. On the same day, Fenster exercised options to purchase 200,000 shares for $1,016,000. These transactions were executed under a Rule 10b5-1 trading plan, with Fenster now directly owning 1,474,926 shares, including restricted stock units.

**2. Sunrun (NASDAQ:RUN) Director Edward Harris Fenster Sells 133,256 Shares**
- Source: MarketBeat | 20251209T020951 | Neutral | Relevance: 99%
-  Sunrun (NASDAQ:RUN) Director Edward Harris Fenster sold 133,256 shares of the company's stock on December 5th, totaling over $2.4 million, reducing his position by 8.29%. Despite analysts rating the stock a "Moderate Buy" with an average target of $19.58, Sunrun reported a negative net margin of -106.5%. The company recently beat quarterly EPS and revenue estimates, with revenue up 34.9% year-over-year.

**3. Edgestream Partners L.P. Buys 107,377 Shares of Sunrun Inc. $RUN**
- Source: MarketBeat | 20251207T043255 | Somewhat-Bullish | Relevance: 98%
-  Edgestream Partners L.P. significantly increased its stake in Sunrun Inc. by 124.5%, purchasing an additional 107,377 shares to hold a total of 193,632 shares valued at approximately $1.584 million. This move comes as Sunrun exceeded earnings expectations in its latest quarter, reporting $0.06 EPS against an anticipated $0.01 and revenues of $724.6 million, a 34.9% year-over-year increase. Despite a negative net margin, analysts have issued a "Moderate Buy" rating with an average price target of $19.58, with some firms raising their targets.

**4. Sunrun (RUN) Stock Up 117%: Why Analysts Are Cautious on Solar Giant | 2025 Report - News and Statistics**
- Source: IndexBox | 20251206T043255 | Neutral | Relevance: 98%
- Sunrun's stock has surged 117% in the past six months, yet analysts remain cautious due to flat revenue, negative free cash flow averaging -38.4% over five years, and substantial debt ($14.69 billion) exceeding cash ($1.16 billion). The company burned through $779.9 million in cash last year, leading analysts to express concerns about financial risk and potential shareholder dilution. Despite a reasonable forward P/E, analysts suggest better investment opportunities exist.

**5. Russell Investments Group Ltd. Grows Position in Sunrun Inc. $RUN**
- Source: MarketBeat | 20251206T043255 | Somewhat-Bullish | Relevance: 98%
-  Russell Investments Group Ltd. increased its stake in Sunrun Inc. (NASDAQ:RUN) by 32% during the second quarter, bringing their total holdings to 756,567 shares valued at $6.19 million. This move is part of broader institutional interest, with hedge funds and institutional investors collectively owning 91.69% of Sunrun's stock. The company recently reported better-than-expected quarterly earnings, although it remains unprofitable, and analysts generally maintain a favorable view with a "Moderate Buy" consensus.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Morgan Stanley | $21 | $20 | +5% |
| 2025-11-11 | Wells Fargo | $21 | $14 | +50% |
| 2025-11-10 | Guggenheim | $27 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Morgan Stanley | main | Equal-Weight |
| 2025-11-11 | Wells Fargo | main | Overweight |
| 2025-11-10 | Guggenheim | up | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 15 ($4.47M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 55.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Blackrock Inc.: 16.1% (+0.2%)
- Vanguard Group Inc: 10.4% (+1.2%)
- Greenvale Capital, L: 5.8% (-2.1%)
- Shaw D.E. & Co., Inc: 4.1% (+533.8%)
- State Street Corpora: 4.0% (-0.9%)

### Key Risks

1. High beta (2.35) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Insider selling cluster: $4.5M in recent transactions.
3. High short interest (28.7%, 6.3 days to cover): squeeze risk or crowded bearish bet.
4. Near-term weakness: 6.3% below SMA50 despite long-term uptrend.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.45 indicates undervaluation relative to growth. Analyst sentiment positive (2 raises, avg +28%). Insider selling cluster ($4.5M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $4.2B |
| Beta | 2.35 |
| 52W Range | $5.38 - $22.44 |
| Short Interest | 28.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.45 |
| Forward P/E | 23.5 |
| Current P/E | 13.2 |
| YoY Growth | -43.6% |
| EPS Direction | FALLING |

### Technicals

MRS_20 stable at -5.0% (minimal 5-day change). Below STRENGTH zone by 9.0pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.1%) - potential reversal signal. Underperforming sector by 6.1pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.47x) but short-term weakness (below SMA20). RSI neutral at 46. Volume at 58% of 20MA suggests lack of conviction.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -4.96% (CS: 15) | Weak |
| RSI_14 | 46.4 | Neutral |
| MACD Histogram | -0.09 | Bearish |
| vs SMA20 | 0.970x | Below |
| vs SMA50 | 0.937x | Below |
| vs SMA200 | 1.474x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $18.06
- **Stop Loss:** $15.38 (14.8% risk)
- **Target:** $23.42 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 447
- **Position Value:** $8,072.82
- **Portfolio %:** 8.07%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

### Earnings

**Next:** 2026-02-26 (Est: $-0.07)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.12 | $0.06 | -48.7% |
| 2025Q2 | $-0.12 | $1.07 | +1030.4% |
| 2025Q1 | $-0.27 | $0.20 | +173.5% |
| 2024Q4 | $-0.19 | $1.41 | +837.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*